MYC and neoplasm: In solid tumors, USP3 is significantly upregulated in gastric cancer, glioblastoma, and breast cancer, where it stabilizes oncoproteins (e.g., c-Myc, MDM2) to promote tumor proliferation, metastasis, and therapy resistance.